Armenia's pharmaceutical market is supplied by a diverse array of countries, including China, European Union (EU) manufacturers, domestic producers, and other emerging markets. In 2024, Armenia imported pharmaceutical products totaling approximately $238.51 million. While specific market share data for each supplying country is limited, available information highlights the significant presence of certain exporters.
In 2019, German-made drugs accounted for 16% of Armenia's pharmaceutical imports, followed by French-made drugs and Russian-made drugs. Notably, in 2019, three companies—Vaga Pharm LLC, Alfa Pharm Import CJSC, and Natali Pharm LLC—collectively imported 60.3% of all drugs into Armenia. (hetq.am)
China's pharmaceutical exports to Armenia were valued at $2.05 million in 2024, indicating a growing presence in the market. Additionally, Armenia imports pharmaceutical products from countries such as the United States, with imports totaling $44.75 million in 2024.
Domestic production in Armenia also contributes to the pharmaceutical supply, though specific data on its market share is not readily available. The presence of other emerging markets in Armenia's pharmaceutical sector is evident, but detailed market share information is scarce.
